Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Signum Dermalogix Inc.
PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Signum Dermalogix Inc., a private biopharmaceutical company focused on developing new and innovative dermatological products and services has entered into a partnership with Elizabeth Arden, Inc. focusing on a semi-exclusive global license for the cosmetic functional ingredient Arazine™ (N-acetyl-S-farnesyl-cysteine) as well as developing new screening methodologies to measure the anti-oxidant potential of Arden's other product ingredients.
Arazine™, initially discovered at Princeton University possesses anti-inflammatory and anti-oxidant properties making it an ideal complement with Idebenone-ester as key ingredients in Elizabeth Arden's Prevage® Anti-aging + Intensive Repair Daily Serum product.
Arazine™ is the first cosmetic ingredient from Signum Dermalogix's novel technology platform to be commercialized. Maxwell Stock, CEO of Signum Dermalogix commented, "We are excited about our partnership with Arden especially given their commitment to bringing a scientific approach to developing new and innovative skin care products. We believe this is just the beginning of a dynamic collaboration that will enable the development of a first in class line of skin care products."
Dr. Eduardo Perez, VP of R&D stated, "With Elizabeth Arden's decades of experience in skin care and our R&D and chemical expertise, we look forward to assisting Elizabeth Arden's efforts in producing innovative, high quality skin care products supported with robust scientific data."
Given the successful launch of Arazine™ in the Prevage® line, Signum Dermalogix is now focused on developing a second generation of novel cosmetic ingredients as well as finding a partner to commercialize Arazine™ in the physician dispensed channel.
About Signum Dermalogix
Signum Dermalogix was founded in 2011 and is a spin-out of Signum Biosciences. Signum Dermalogix is a dermatology focused company developing novel cosmetic ingredients and drug compounds. Signum Dermalogix also provides dermatology testing, custom assay development and analytical services. For more information please visit: www.signumdermalogix.com.
About Elizabeth Arden
Elizabeth Arden is a global prestige beauty products company with an extensive portfolio of prestige beauty brands sold in over 100 countries. The company's brand portfolio includes Elizabeth Arden skincare, color, and fragrance products, PREVAGE® anti-aging formulas, the celebrity fragrance brands of Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, and Usher; the designer fragrance brands of Juicy Couture, Alberta Ferretti, Alfred Sung, Badgley Mischka, Bob Mackie, Geoffrey Beene, Halston, John Varvatos, Kate Spade, Lucky Brand, and Rocawear; and the lifestyle fragrance brands Curve, Giorgio Beverly Hills, and PS Fine Cologne.
©2012 PR Newswire. All Rights Reserved.